Apolipoprotein E and Alzheimer's disease: findings, hypotheses, and potential mechanisms

N Koutsodendris, MR Nelson, A Rao… - Annual Review of …, 2022 - annualreviews.org
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder that involves
dysregulation of many cellular and molecular processes. It is notoriously difficult to develop …

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

F Yin - The FEBS journal, 2023 - Wiley Online Library
Alzheimer's disease (AD) is an age‐associated neurodegenerative disorder with
multifactorial etiology, intersecting genetic and environmental risk factors, and a lack of …

Role of cholesterol and sphingolipids in brain development and neurological diseases

G Hussain, J Wang, A Rasul, H Anwar, A Imran… - Lipids in health and …, 2019 - Springer
Brain is a vital organ of the human body which performs very important functions such as
analysis, processing, coordination, and execution of electrical signals. For this purpose, it …

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies

P Sharma, P Srivastava, A Seth, PN Tripathi… - Progress in …, 2019 - Elsevier
AD is a progressive neurodegenerative disorder and a leading cause of dementia in an
aging population worldwide. The enormous challenge which AD possesses to global …

Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases

D Yang, X Wang, L Zhang, Y Fang, Q Zheng, X Liu… - Cell & Bioscience, 2022 - Springer
The importance of neuroglia in maintaining normal brain function under physiological and
pathological conditions has been supported by growing evidence in recent years. The most …

Structural brain changes in aging: courses, causes and cognitive consequences

AM Fjell, KB Walhovd - Reviews in the Neurosciences, 2010 - degruyter.com
The structure of the brain is constantly changing from birth throughout the lifetime, meaning
that normal aging, free from dementia, is associated with structural brain changes. This …

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

WJ Strittmatter, AM Saunders… - Proceedings of the …, 1993 - National Acad Sciences
Apolipoprotein E is immunochemically localized to the senile plaques, vascular amyloid,
and neurofibrillary tangles of Alzheimer disease. In vitro, apolipoprotein E in cerebrospinal …

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

WJ Strittmatter, KH Weisgraber… - Proceedings of the …, 1993 - National Acad Sciences
Apolipoprotein E (apoE), a plasma apolipoprotein that plays a central role in lipoprotein
metabolism, is localized in the senile plaques, congophilic angiopathy, and neurofibrillary …

Cholesterol metabolism in neurons and astrocytes

FW Pfrieger, N Ungerer - Progress in lipid research, 2011 - Elsevier
Cells in the mammalian body must accurately maintain their content of cholesterol, which is
an essential membrane component and precursor for vital signalling molecules. Outside the …

Apolipoprotein e sets the stage: response to injury triggers neuropathology

RW Mahley, Y Huang - Neuron, 2012 - cell.com
Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease and is
associated with poor clinical outcome following traumatic brain injury and other …